SightfileU.S. market data from official filings

ALECTOR INC (ALEC)

Name: ALECTOR INC (ALEC) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001653087 · EDGAR filings · Updated 2026-07-09

ALECTOR INC (ALEC) has reported institutional ownership of 79.6%, with 137 institutional managers holding positions valued at $190.0M per the latest 13F reporting period.

Institutional ownership

79.6%

Institutional managers

137

Reported 13F value

$190.0M

Insider activity

35 trans.

−$894.2K net selling

Latest updates

2026-07-09 — Insider transaction reported (Form 4)
2026-07-08 — Current report (8-K) filed
2026-06-17 — Insider transaction reported (Form 4)
2026-06-17 — Insider transaction reported (Form 4)
2026-06-17 — Insider transaction reported (Form 4)
2026-06-17 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ALECTOR INC has 137 institutional holders and institutional ownership of 79.6%.

Insider activity

Insiders reported 35 transactions (0 buys, 20 sells) across 12 reporting insiders, with a net reported value of −$894.2K.

Related companies

ATRIUM THERAPEUTICS INC (RNA) · CONTEXT THERAPEUTICS INC (CNTX) · INHIBIKASE THERAPEUTICS INC (IKT) · ALX ONCOLOGY HLDGS INC (ALXO) · EVOLUS INC (EOLS) · ARCTURUS THERAPEUTICS HLDGS (ARCT)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-09.